OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company’s Real World Data Footprint into Korea and the Asia Pacific Region
October 7, 2026
Health
-
-
Owlet Launches Partnership with VillageFor to Advocate For Better Mental Health Support for New and Expecting Parents
October 7, 2026
-
Curaleaf Enhances Offer to Acquire Aurora Cannabis
October 5, 2026
-
Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in its Transition Toward Commercial Revenue Generation
October 1, 2026
-
Radnostix Signs Definitive Agreement to Divest DUF6 and Fluorine Assets to NANO Nuclear
October 1, 2026
-
Corvex Launches Security-First AI Inference Platform for Open-Weight Models
September 30, 2026
-
OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data Solution
September 30, 2026
-
Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives
September 29, 2026
-
Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis
September 17, 2026
-
VitalHub Announces Expansion of AI Capabilities with Launch of AI Scribe
September 15, 2026
-
Glucotrack Announces $11.5 Million Financing
September 11, 2026
-
Trinity Biotech’s Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center Infrastructure
September 9, 2026
-
PRF Technologies to Establish GridFeed(TM) as a Standalone Subsidiary to Pursue Strategic Alliances for Its AI-Driven Renewable Energy Trading Platform
September 9, 2026
-
Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets
September 8, 2026
-
cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women’s Beauty, Weight Loss and Longevity Wellness
September 2, 2026
-
Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company
September 2, 2026